Stockreport

Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update

Third Harmonic Bio, Inc.  (THRD) 
PDF THB335 Phase 1 SAD/MAD clinical trial progressing; study now on track to report clinical results in 1Q’25 Strong financial position with cash and cas [Read more]